ZP4207 + Glucagon
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Hypoglycemia
Conditions
Hypoglycemia
Trial Timeline
Dec 1, 2014 → Apr 1, 2015
NCT ID
NCT02367053About ZP4207 + Glucagon
ZP4207 + Glucagon is a phase 1 stage product being developed by Zealand Pharma for Hypoglycemia. The current trial status is completed. This product is registered under clinical trial identifier NCT02367053. Target conditions include Hypoglycemia.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02367053 | Phase 1 | Completed |
Competing Products
20 competing products in Hypoglycemia